Population-based study of invasive disease due to β-Hemolytic streptococci of groups other than A and B

Clinical Infectious Diseases

Volumn 48, Issue 6, 2009, Pages 706-712

  Broyles, Laura N ^a   Van Beneden, Chris ^b   Beall, Bernard ^b   Facklam, Richard ^b   Lynn Shewmaker, P ^b   Malpiedi, Paul ^c   Daily, Pamala ^d   Reingold, Arthur ^d,e   Farley, Monica M ^a,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c ATLANTA VA MEDICAL CENTER   (United States)

^d CALIFORNIA EMERGING INFECTIONS PROGRAM   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEPHALOSPORIN; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; VANCOMYCIN;

ABDOMINAL INFECTION; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BETA HEMOLYTIC STREPTOCOCCUS; COMORBIDITY; ETHNICITY; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MICROBIOLOGY; MORTALITY; PERITONITIS; POPULATION BASED CASE CONTROL STUDY; PREVENTION AND CONTROL; PRIORITY JOURNAL; SKIN INFECTION; SOFT TISSUE INFECTION; SPECIES INVASION; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS DYSGALACTIAE; ADOLESCENT; AGE; BACTERIAL SKIN DISEASE; CHILD; CLASSIFICATION; COMMUNICABLE DISEASE; ETHNIC GROUP; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR; STREPTOCOCCUS; STREPTOCOCCUS INFECTION; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CALIFORNIA; CHILD; COMMUNITY-ACQUIRED INFECTIONS; ETHNIC GROUPS; FEMALE; GEORGIA; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PERITONITIS; RISK FACTORS; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; YOUNG ADULT;

EID: 62449203150     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/597035     Document Type: Article

References (30)

1. Johnson CC, Tunkel AR. Viridans streptococci, Groups C and G streptococci, and Gemella morbilhrum In: Mandell G, Bennett J, Dolin R, eds. Principles and practice of infectious diseases. 6th ed. Philadelphia: Churchill Livingstone, 2005:2434-51.
2. Humar D, Datta V, Bast D, Beall B, Azavedi JCS, Nizet V. Streptolysin S and necrotizing infections produced by group G streptococcus. Lancet 2002;359:124-9.
3. Cohen-Poradosu R, Jaffe J, Lavi D, et al. Group G streptococcal bacteremia in Jerusalem. Emerg Infect Dis 2004; 10:1455-60.
4. Skogberg K, Simonen H, Renkonen O, Valtonen V. Beta-haemolytic group A, B, C, and G streptococcal septicaemia: a clinical study. Scand J Infect Dis 1988;20:119-25.
5. Sylvetsky N, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM. Bacteremia due to β-hemolytic Streptococcus group G: increasing incidence and clinical characteristics of patients. Am J Med 2002; 112:622-6.
6. Facklam R. What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev 2002; 15:613-30.
7. Kawamura Y, Hou SG, Sultana F, Miura H, Ezaki T. Determination of 16S rRNA sequences of Streptococcus mitis and Streptococcus gordonii and phylogenetic relationships among member of the genus Streptococcus Int J Syst Bacteriol 1995; 45:406-8.
8. Spellerberg B, Brandt C. Streptococcus In: Murray PR, Baron EJ, Jor-gensen JJ, Landry ML, Pfaller MA, eds. Manual of clinical microbiology. 9th ed. Washington, DC: ASM Press, 2007:412-29.
9. Mirzanejad Y, Stratton CW. Streptococcus anginosus Group. In: Mandell G, Bennett J, Dolin R, eds. Principles and practice of infectious diseases. 6th ed. Philadelphia: Churchill Livingstone, 2005:2451-7.
10. Ruoff KL, Kunz LJ, Ferraro MJ. Occurrence of Streptococcus milleri among β-hemolytic streptococci isolated from clinical specimens. J Clin Microbiol 1985;22:149-51.
11. Lawrence J, Yajko DM, Hadley WK. Incidence and characterization of(3-hemolytic Streptococcus milleri and differentiation from S. pyogenes( group A), S. equisimilis( group C), and large colony group G streptococci. J Clin Microbiol 1985;22:772-7.
12. Shlaes DM, Lerner PI, Wolinsky E, Gopalakrishna KV. Infections due to Lancefield group F and related streptococci. Medicine 1981; 60:197-206.
13. Facklam R, Elliott JA. Identification, classification, and clinical relevance of catalase-negative, gram-positive cocci, excluding the streptococci and enterococci. Clin Microbiol Rev 1995;8:479-95.
14. Freney J, Bland S, Etienne J, et al. Description and evaluation of the semiautomated 4-h Rapid ID 32 Strep method for identification of streptococci and members of related genera. J Clin Microbiol 1992;30:2657-61.
15. Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 1996; 34:953-8.
16. Li Z, Sakota V, Jackson D, et al. The array of M protein gene subtypes in 1061 recent invasive group A streptococcal isolates recovered from the Active Bacterial Core Surveillance. J Infect Dis 2003; 188:1587-92.
17. Centers for Disease Control and Prevention. Streptococcus laboratory protocols. 2008. Available at: http://wwvv.cdc.gov/ncidod/ biotech/strep/protocols.htm. Accessed 5 May 2008.
18. Clinical and Laboratory Standards Institute( CLSI). Performance standards for antimicrobial susceptibility testing: seventeenth informational supplement. CLSI document M100-S17. Wayne, PA: CLSI, 2007.
19. O'Loughlin RE, Roberson A, Cieslak PR, et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis 2007;45:853-62.
20. Auckenthaler R, Hermans PE, Washington JA. Group G streptococcal bacteremia: clinical study and review of the literature. Rev Infect Dis 1983;5:196-204.
21. Ekelund K, Skinhoj P, Madsen J, Konradsen HB. Invasive group A, B, C, and G streptococcal infections in Denmark 1999-2002: epidemiological and clinical aspects. Clin Microbiol Infect 2005; 11:569-76.
22. Lam K, Bayer AS. Serious infections due to group G streptococci. Am J Med 1983;75:561-70.
23. Vartian C, Lerner PI, Shlaes D, Gopalakrishna KV. Infections due to Lancefield group G streptococci. Medicine 1985;64:75-87.
24. Woo PCY, Fung AMY, Lau SKP, Wong SSY, Yuen K. Group G 0-hemolytic streptococcal bacteremia characterized by 16S ribosomal RNA gene sequencing. J Clin Microbiol 2001;39:3147-55.
25. Salata RA, Lerner PI, Shlaes DM, Gopalakrishna KV, Wolinksy E. Infections due to Lancefield group C streptococci. Medicine 1989; 68:225-38.
26. Prabhu RM, Piper KE, Baddour LM, et al. Antimicrobial susceptibility patterns among viridans group streptococcal isolates from infective endocarditis patients from 1971 to 1986 and 1994 to 2002. Antimicrob Agents Chemother 2004;48:4463-5.
27. Kataja J, Huovinen P, Muotiala A, et al. Clonal spread of the group A Streptococcus with the new type of erythromycin resistance. Finnish Study Group for Antimicrobial Resistance. J Infect Dis 1998; 177:786-9.
28. McMurry LM, Levy SB. Tetracycline resistance in gram-positive bacteria. In: Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Rood JI, eds. Gram-positive pathogens. Washington, DC: ASM Press, 2000:660-77.
29. Van Beneden C, Lynfield R, Glennen A, et al. Resistance among invasive group A streptococcal infections, United States, 1999-2006[poster P64], In: Program and abstracts of the 17th Lancefield International Symposium on Streptococci and Streptococcal Diseases( Porto Heli, Greece). Athens, Greece: National and Kapodistrian University of Greece; London: Health Protection Agency, 2008:159.
30. Lopardo HA, Vidal P, Sparo M, et al. Six-month multicenter study on invasive infections due to Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis in Argentina. J Clin Microbiol 2005; 43:802-7.